Existing classifications of public service innovation are largely derived from a private sector perspective and an internal orientation, overlooking their public value and collaborative nature. In this article, we present a typology for defining and classifying innovation in public service organizations that comprises two dimensions: ‘innovation focus’ (three public value creation processes of strategy, capacity and operations), and ‘innovation locus’ (internal and external). Together, these result in six types of innovation: mission, policy, management, partner, service, and citizen. A preliminary assessment is presented. The implications of the typology for understanding public service innovation are discussed.
We aim to provide a systematic review and meta-analysis of the prevalence rates of mental health symptoms among major African populations during the COVID-19 pandemic. We include articles from PubMed, Embase, Web of Science, PsycINFO, and medRxiv between 1 February 2020 and 6 February 2021, and pooled data using random-effects meta-analyses. We identify 28 studies and 32 independent samples from 12 African countries with a total of 15,071 participants. The pooled prevalence of anxiety was 37% in 27 studies, of depression was 45% in 24 studies, and of insomnia was 28% in 9 studies. The pooled prevalence rates of anxiety, depression, and insomnia in North Africa (44%, 55%, and 31%, respectively) are higher than those in Sub-Saharan Africa (31%, 30%, and 24%, respectively). We find (a) a scarcity of studies in several African countries with a high number of COVID-19 cases; (b) high heterogeneity among the studies; (c) the extent and pattern of prevalence of mental health symptoms in Africa is high and differs from elsewhere—more African adults suffer from depression rather than anxiety and insomnia during COVID 19 compared to adult populations in other countries/regions. Hence, our findings carry crucial implications and impact future research to enable evidence-based medicine in Africa.
19 April 2022 in Epidemiology and Psychiatric Sciences
Aims: There is a lack of evidence related to the prevalence of mental health symptoms as well as their heterogeneities during the coronavirus disease 2019 (COVID-19) pandemic in Latin America, a large area spanning the equator. The current study aims to provide meta-analytical evidence on mental health symptoms during COVID-19 among frontline healthcare workers, general healthcare workers, the general population and university students in Latin America.Methods: Bibliographical databases, such asPubMed, Embase, Web of Science, PsycINFOandmedRxiv, were systematically searched to identify pertinent studies up to August 13, 2021. Two coders performed the screening using predefined eligibility criteria. Studies were assigned quality scores using the Mixed Methods Appraisal Tool. The double data extraction method was used to minimise data entry errors.Results: A total of 62 studies with 196 950 participants in Latin America were identified. The pooled prevalence of anxiety, depression, distress and insomnia was 35%, 35%, 32% and 35%, respectively. There was a higher prevalence of mental health symptoms in South America compared to Central America (36%v. 28%,p< 0.001), in countries speaking Portuguese (40%)v.Spanish (30%). The pooled prevalence of mental health symptoms in the general population, general healthcare workers, frontline healthcare workers and students in Latin America was 37%, 34%, 33% and 45%, respectively.Conclusions: The high yet heterogenous level of prevalence of mental health symptoms emphasises the need for appropriate identification of psychological interventions in Latin America.
15 February 2022 in European Journal of Psychotraumatology
To perform a systematic and meta-analysis on the prevalence rates of mental health symptoms including anxiety and depression during the COVID-19 pandemic in the general population in Eastern Europe... The pooled prevalence of anxiety and depression in Eastern Europe were 30% and 27%, respectively.Forty-one per cent of frontline healthcare workers suffered mental health symptoms.Southeastern Euro... Objetivo: Realizar un metanálisis sistemático sobre las tasas de prevalencia de síntomas de salud mental, incluidos ansiedad y depresión durante la pandemia de COVID-19 en la población general de E... 目的: 对东欧普通人群以及三个选定亚组人群 (学生, 普通医疗工作者及前线医护人员) 在 COVID-19 疫情期间包括焦虑和抑郁在内的心理健康症状的流行率进行系统和元分析。数据来源: 截至 2021 年 2 月 6 日的 PubMed, Embase, Web of Science, PsycINFO 和 medRxiv 中的研究。资格标准和数据分析: 东欧 COVID-19 疫情期间一般...
26 November 2021 in Psychiatry and Clinical Neurosciences
Aims: The Covid‐19 pandemic has had a substantial impact on the mental health of the general public and high‐risk groups worldwide. Due to its proximity and close links to China, Southeast Asia was one of the first regions to be affected by the outbreak. The aim of this systematic review was to evaluate the prevalence of anxiety, depression and insomnia in the general adult population and healthcare workers (HCWs) in Southeast Asia during the course of the first year of the pandemic.Methods: Several literature databases were systemically searched for articles published up to February 2021 and two reviewers independently evaluated all relevant studies using pre‐determined criteria. The prevalence rates of mental health symptoms were calculated using a random‐effect meta‐analysis model.Results: In total, 32 samples from 25 studies with 20 352 participants were included. Anxiety was assessed in all 25 studies and depression in 15 studies with pooled prevalence rates of 22% and 16%, respectively. Only two studies assessed insomnia, which was estimated at 19%. The prevalence of anxiety and depression was similar among frontline HCWs (18%), general HCWs (17%), and students (20%) while being noticeably higher in the general population (27%).Conclusions: This is the first systematic review to investigate the mental health impact of the Covid‐19 pandemic in Southeast Asia. A considerable proportion of the general population and HCWs reported mild to moderate symptoms of anxiety and depression; the pooled prevalence rater, however, remain significantly lower than those reported in other areas such as China and Europe.